Dr. Karsten Fischer

• CEO of Memo Therapeutics since Series B
• Former Partner at BioMedPartners with prior experience in equity capital markets at WestLB, sales & marketing at Sanofi and management consulting at McKinsey
• PhD in Infection Biology